Hepatic steatosis associated with 69% higher risk for major adverse cardiovascular events

Individuals with hepatic steatosis appeared to have higher amounts of noncalcified coronary plaque and were almost twice as likely to experience major adverse cardiovascular events compared with those without fatty liver disease, data show.Noncalcified plaque, which is lipid rich and susceptible to rupture that can lead to blood clots, accounted for approximately 11% of this elevated risk. The